ESC 365 - Late sodium current inhibitors for the treatment of inducible obstruction and diastolic dysfunction in hypertrophic cardiomyopathy: a study on human myocardium.

Open Access

Late sodium current inhibitors for the treatment of inducible obstruction and diastolic dysfunction in hypertrophic cardiomyopathy: a study on human myocardium.

Session: Poster session 1 - Cardiomyopathies and fibrosis

Topic: Cardiomyopathies

Speaker: Doctor C. Ferrantini (Florence, IT)

Event: Frontiers in CardioVascular Biology 2016

Congress Presentation

Add to my library

About the speaker

Doctor Cecilia Ferrantini

University of Florence, Florence (Italy)

1 presentation

0 follower

12 more presentations in this session

Cardiomyopathies and fibrosis - Poster discussant:

Plakophilin-2 haploinsufficiency leads to impaired canonical Wnt signaling in ARVC patient

Speaker: Doctor A. Khudiakov (Saint Petersburg, RU)

Improved technique for customized, easier, safer and more reliable transverse aortic arch banding and debanding in mice as a model of pressure overload hypertrophy

Speaker: Doctor J. Nistal (Santander, ES)

Angiotensin II receptor antagonist fimasartan has protective role of left ventricular fibrosis and remodeling in the rat ischemic heart

Speaker: Professor S. Park (Seoul, KR)

Role of High-Mobility Group Box 1 (HMGB1) redox state on cardiac fibroblasts activities and heart function after myocardial infarction

Speaker: Miss S. Di Maggio (Milan, IT)

Access the full session

Poster session 1 - Cardiomyopathies and fibrosis

Speakers: Doctor C. Ferrantini, Doctor A. Khudiakov, Doctor J. Nistal, Professor S. Park, Miss S. Di Maggio

About the event

Frontiers in CardioVascular Biology 2016

8 July - 10 July 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources